[1] |
|
[2] |
MARTIN N, MANOHARAN K, DAVIES C,et al. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction[J]. Cochrane Database Syst Rev, 2021, 5(5):CD012721. DOI: 10.1002/14651858.CD012721.pub3.
|
[3] |
ANAND I S, KONSTAM M A, KLEIN H U,et al. Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF,INOVATE-HF,and NECTAR-HF[J]. ESC Heart Fail, 2020, 7(1):75-83. DOI: 10.1002/ehf2.12592.
|
[4] |
ARIMURA T, SAKU K, KAKINO T,et al. Intravenous electrical vagal nerve stimulation prior to coronary reperfusion in a canine ischemia-reperfusion model markedly reduces infarct size and prevents subsequent heart failure[J]. Int J Cardiol, 2017, 227:704-710. DOI: 10.1016/j.ijcard.2016.10.074.
|
[5] |
DICARLO L A, LIBBUS I, KUMAR H U,et al. Autonomic regulation therapy to enhance myocardial function in heart failure patients:the ANTHEM-HFpEF study[J]. ESC Heart Fail, 2018, 5(1):95-100. DOI: 10.1002/ehf2.12241.
|
[6] |
SANT'ANNA L B, COUCEIRO S L M, FERREIRA E A,et al. Vagal neuromodulation in chronic heart failure with reduced ejection fraction:a systematic review and meta-analysis[J]. Front Cardiovasc Med, 2021, 8:766676. DOI: 10.3389/fcvm.2021.766676.
|
[7] |
HADAYA J, ARDELL J L. Autonomic modulation for cardiovascular disease[J]. Front Physiol, 2020, 11:617459. DOI: 10.3389/fphys.2020.617459.
|
[8] |
SHARMA K, PREMCHAND R K, MITTAL S,et al. Long-term follow-up of patients with heart failure and reduced ejection fraction receiving autonomic regulation therapy in the ANTHEM-HF pilot study[J]. Int J Cardiol, 2021, 323:175-178. DOI: 10.1016/j.ijcard.2020.09.072.
|
[9] |
OTTAVIANI M M, MACEFIELD V G. Structure and functions of the vagus nerve in mammals[J]. Compr Physiol, 2022, 12(4):3989-4037. DOI: 10.1002/cphy.c210042.
|
[10] |
SHAFFER C, BARRETT L F, QUIGLEY K S. Signal processing in the vagus nerve:hypotheses based on new genetic and anatomical evidence[J]. Biol Psychol, 2023, 182:108626. DOI: 10.1016/j.biopsycho.2023.108626.
|
[11] |
|
[12] |
DOLPHIN H, DUKELOW T, FINUCANE C,et al. "The wandering nerve linking heart and mind"-the complementary role of transcutaneous vagus nerve stimulation in modulating neuro-cardiovascular and cognitive performance[J]. Front Neurosci, 2022, 16:897303. DOI: 10.3389/fnins.2022.897303.
|
[13] |
CARAVACA A S, GALLINA A L, TARNAWSKI L,et al. Vagus nerve stimulation promotes resolution of inflammation by a mechanism that involves Alox15 and requires the α7nAChR subunit[J]. Proc Natl Acad Sci USA, 2022, 119(22):e2023285119. DOI: 10.1073/pnas.2023285119.
|
[14] |
STAVRAKIS S, ELKHOLEY K, MORRIS L,et al. Neuromodulation of inflammation to treat heart failure with preserved ejection fraction:a pilot randomized clinical trial[J]. J Am Heart Assoc, 2022, 11(3):e023582. DOI: 10.1161/JAHA.121.023582.
|
[15] |
SABBAH H N, ILSAR I, ZARETSKY A,et al. Vagus nerve stimulation in experimental heart failure[J]. Heart Fail Rev, 2011, 16(2):171-178. DOI: 10.1007/s10741-010-9209-z.
|
[16] |
ALLEN E, PONGPAOPATTANAKUL P, CHAUHAN R A,et al. The effects of vagus nerve stimulation on ventricular electrophysiology and nitric oxide release in the rabbit heart[J]. Front Physiol, 2022, 13:867705. DOI: 10.3389/fphys.2022.867705.
|
[17] |
YANCY C W, JESSUP M, BOZKURT B,et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America[J]. Circulation, 2017, 136(6):e137-161. DOI: 10.1161/CIR.0000000000000509.
|
[18] |
COOPER C M, FARRAND A Q, ANDRESEN M C,et al. Vagus nerve stimulation activates nucleus of solitary tract neurons via supramedullary pathways[J]. J Physiol, 2021, 599(23):5261-5279. DOI: 10.1113/JP282064.
|
[19] |
MARTLÉ V, VAN HAM L M, BOON P,et al. Vagus nerve stimulator placement in dogs:surgical implantation technique,complications,long-term follow-up,and practical considerations[J]. Vet Surg, 2016, 45(1):71-78. DOI: 10.1111/vsu.12427.
|
[20] |
HARCOURT-BROWN T R, CARTER M. Implantable vagus nerve stimulator settings and short-term adverse effects in epileptic dogs[J]. J Vet Intern Med, 2021, 35(5):2350-2358. DOI: 10.1111/jvim.16226.
|
[21] |
LI Y, XUAN Y H, LIU S S,et al. Short-term vagal nerve stimulation improves left ventricular function following chronic heart failure in rats[J]. Mol Med Rep, 2015, 12(2):1709-1716. DOI: 10.3892/mmr.2015.3597.
|
[22] |
DE FERRARI G M, STOLEN C, TUINENBURG A E,et al. Long-term vagal stimulation for heart failure:eighteen month results from the NEural Cardiac TherApy foR Heart Failure(NECTAR-HF)trial[J]. Int J Cardiol, 2017, 244:229-234. DOI: 10.1016/j.ijcard.2017.06.036.
|
[23] |
ZHOU L P, FILIBERTI A, HUMPHREY M B,et al. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction[J]. Exp Physiol, 2019, 104(1):28-38. DOI: 10.1113/EP087351.
|
[24] |
|
[25] |
HOU B, WANG D D, QIU Y H,et al. Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure[J]. J Clin Invest, 2020, 130(11):6054-6063. DOI: 10.1172/JCI138538.
|
[26] |
LUO B, WU Y, LIU S L,et al. Vagus nerve stimulation optimized cardiomyocyte phenotype,sarcomere organization and energy metabolism in infarcted heart through FoxO3A-VEGF signaling[J]. Cell Death Dis, 2020, 11(11):971. DOI: 10.1038/s41419-020-03142-0.
|
[27] |
SUN Y, CHAO S Y, OUYANG H,et al. Hybrid nanogenerator based closed-loop self-powered low-level vagus nerve stimulation system for atrial fibrillation treatment[J]. Sci Bull, 2022, 67(12):1284-1294. DOI: 10.1016/j.scib.2022.04.002.
|
[28] |
XUAN Y H, LIU S S, LI Y,et al. Short-term vagus nerve stimulation reduces myocardial apoptosis by downregulating microRNA-205 in rats with chronic heart failure[J]. Mol Med Rep, 2017, 16(5):5847-5854. DOI: 10.3892/mmr.2017.7344.
|
[29] |
WANG Y, ZHANG Y. LncRNA CAIF suppresses LPS-induced inflammation and apoptosis of cardiomyocytes through regulating miR-16 demethylation[J]. Immun Inflamm Dis, 2021, 9(4):1468-1478. DOI: 10.1002/iid3.498.
|
[30] |
ZHANG X Y, GAO Y K, WU H Y,et al. LncRNA HOX transcript antisense RNA mitigates cardiac function injury in chronic heart failure via regulating microRNA-30a-5p to target KDM3A[J]. J Cell Mol Med, 2022, 26(5):1473-1485. DOI: 10.1111/jcmm.17160.
|
[31] |
FENG Y L, YAN B, CHENG H J,et al. Knockdown circ_0040414 inhibits inflammation,apoptosis and promotes the proliferation of cardiomyocytes via miR-186-5p/PTEN/AKT axis in chronic heart failure[J]. Cell Biol Int, 2021, 45(11):2304-2315. DOI: 10.1002/cbin.11678.
|
[32] |
LI T, QIAN D, GUOYAN J,et al. Downregulated long noncoding RNA LUCAT1 inhibited proliferation and promoted apoptosis of cardiomyocyte via miR-612/HOXA13 pathway in chronic heart failure[J]. Eur Rev Med Pharmacol Sci, 2020, 24(1):385-395. DOI: 10.26355/eurrev_202001_19937.
|
[33] |
BEAUMONT E, SOUTHERLAND E M, HARDWICK J C,et al. Vagus nerve stimulation mitigates intrinsic cardiac neuronal and adverse myocyte remodeling postmyocardial infarction[J]. Am J Physiol Heart Circ Physiol, 2015, 309(7):H1198-1206. DOI: 10.1152/ajpheart.00393.2015.
|
[34] |
|
[35] |
NEARING B D, LIBBUS I, CARLSON G M,et al. Chronic vagus nerve stimulation is associated with multi-year improvement in intrinsic heart rate recovery and left ventricular ejection fraction in ANTHEM-HF[J]. Clin Auton Res, 2021, 31(3):453-462. DOI: 10.1007/s10286-021-00780-y.
|
[36] |
KONSTAM M A, MANN D L, UDELSON J J E,et al. Advances in our clinical understanding of autonomic regulation therapy using vagal nerve stimulation in patients living with heart failure[J]. Front Physiol, 2022, 13:857538. DOI: 10.3389/fphys.2022.857538.
|
[37] |
KUMAR H U, NEARING B D, MITTAL S,et al. Autonomic regulation therapy in chronic heart failure with preserved/mildly reduced ejection fraction:anthem-HFpEF study results[J]. Int J Cardiol, 2023, 381:37-44. DOI: 10.1016/j.ijcard.2023.03.030.
|
[38] |
WANG H, SHI J J, SHI S Q,et al. Bibliometric analysis on the progress of chronic heart failure[J]. Curr Probl Cardiol, 2022, 47(9):101213. DOI: 10.1016/j.cpcardiol.2022.101213.
|
[39] |
VERRIER R L, LIBBUS I, NEARING B D,et al. Multifactorial benefits of chronic vagus nerve stimulation on autonomic function and cardiac electrical stability in heart failure patients with reduced ejection fraction[J]. Front Physiol, 2022, 13:855756. DOI: 10.3389/fphys.2022.855756.
|
[40] |
ELAMIN A B A, FORSAT K, SENOK S S,et al. Vagus nerve stimulation and its cardioprotective abilities:a systematic review[J]. J Clin Med, 2023, 12(5):1717. DOI: 10.3390/jcm12051717.
|
[41] |
DU Z Y, WANG J L, LU Y Y,et al. The cardiac protection of Baoyuan Decoction via gut-heart axis metabolic pathway[J]. Phytomedicine, 2020, 79:153322. DOI: 10.1016/j.phymed.2020.153322.
|
[42] |
SUN W J, DU D B, FU T Z,et al. Alterations of the gut microbiota in patients with severe chronic heart failure[J]. Front Microbiol, 2022, 12:813289. DOI: 10.3389/fmicb.2021.813289.
|